CoChat

Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions

Schirmer, Lucas, Srivastava, Rajneesh, Kalluri, Sudhakar Reddy, Böttinger, Susanne, Herwerth, Marina, Carassiti, Daniele, Srivastava, Barkha, Gempt, Jens, Schlegel, Jürgen, Kuhlmann, Tanja, Korn, Thomas, Reynolds, Richard, Hemmer, Bernhard · 2014 · Annals of Neurology
Cited by 45

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Objective: Serum antibodies against the glial potassium channel KIR4.1 are found in a subpopulation of multiple sclerosis (MS) patients. Little is known about the expression of KIR4.1 in human normal brain tissue and in MS lesions. Methods: We analyzed the expression pattern of KIR4.1 in normal brain tissue and MS lesions of the subcortical white matter by immunohistochemistry. Markers of related glial proteins, myelin, and inflammatory cells were analyzed in parallel. Results: KIR4.1 is expressed in oligodendrocytes and astrocytes in the adult human brain. In oligodendrocytes, KIR4.1 appears as a homotetramer channel, in astrocytes as homo‐ and heterotetramer channels together with KIR5.1. In acute MS lesions, KIR4.1 immunoreactivity (IR) was differentially lost on periplaque oligodendrocytes and perivascular astrocytes. In part of acute lesions, complement activation, apoptotic KIR4.1+ glial cells, and phagocytes containing KIR4.1+ fragments accompanied loss of glial KIR4.1 IR. Periplaque reactive astrocytes showed enhanced IR for both KIR4.1 and KIR5.1. In chronic active MS lesions, apart from a general loss of oligodendrocytes in the demyelinated area, we observed a decrease of astroglial KIR4.1 but not glial fibrillary acidic protein IR. In chronic inactive and remyelinating MS lesions, KIR4.1 IR was restored on astrocytes and found in a subset of presumably new myelinating oligodendrocytes. Interpretation: The expression profile of KIR4.1 in glial cells and stage‐dependent alterations of KIR4.1 IR in MS lesions are compatible with an immune response against KIR4.1 at least in a subset of MS patients. Ann Neurol 2014;75:810–828

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24168

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 45

Metadata

Authors
Schirmer, L., Srivastava, R., Kalluri, S. R., Böttinger, S., Herwerth, M., Carassiti, D., Srivastava, B., Gempt, J., Schlegel, J., Kuhlmann, T., Korn, T., Reynolds, R., & Hemmer, B.
Venue
Annals of Neurology
Publisher
Wiley
Published
2014-05-21
Volume
75
Issue
6
Pages
810-828
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1935275454
Cited by
45
References
5
FWCI
4.14
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions. https://app.cochat.ai/papers/10.1002/ana.24168
The paper
Schirmer, L., Srivastava, R., Kalluri, S. R., Böttinger, S., Herwerth, M., Carassiti, D., Srivastava, B., Gempt, J., Schlegel, J., Kuhlmann, T., Korn, T., Reynolds, R., & Hemmer, B. (2014). Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions. Annals of Neurology. https://doi.org/10.1002/ana.24168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.